Zealand Pharma's short bowel syndrome drug wins backing from EU panel

Zealand Pharma received a positive opinion from the Committee for Medicinal Products for Human ​Use recommending approval of its drug ‌candidate Zeydovio for the treatment of short bowel syndrome, the...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。